Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 08 Apr 2025 for ARS Pharmaceuticals, Inc., €122k. Read the official filing
Filing timeline
BuySaleLaura Shawver
Insider track record
Disclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Laura Shawver: trading record in brief
Laura Shawver, listed as chief executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in ARS Pharmaceuticals, Inc., Synthorx, Inc. and Relay Therapeutics, Inc. We count 33 filings; the first trade dates from 24 January 2019 and the latest from 7 April 2025.
The open-market record consists of 5 sales worth €2.6M, with no purchase. Other entries cover 4 share grants and 20 option exercises. 2025 to date brings no purchases and 3 sales.
The record was last updated on 8 April 2025 with an option exercise (€100k) in ARS Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Laura Shawver
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
27,493 shares@ US$4.853.4% of flowCommon StockSEC:0001415889-25-010395:1
50,002 shares@ US$12.30115.7% of flowCommon StockSEC:0001415889-25-010395:2
22,509 shares@ US$4.852.8% of flowCommon StockSEC:0001415889-25-010395:0
400 shares@ US$4.850.1% of flowCommon StockSEC:0001415889-25-007438:0
9,064 shares@ US$3.150.8% of flowCommon StockSEC:0001415889-25-002955:0
40,936 shares@ US$4.855.4% of flowCommon StockSEC:0001415889-25-002955:1
50,000 shares@ US$12.311316.7% of flowCommon StockSEC:0001415889-25-002955:2
50,000 shares@ US$3.154.3% of flowCommon StockSEC:0001415889-25-001053:0
50,000 shares@ US$11.101315.0% of flowCommon StockSEC:0001415889-25-001053:1
67,616 shares@ US$1.272.3% of flowCommon StockSEC:0001415889-24-028350:0
2,997 shares@ US$1.270.1% of flowCommon StockSEC:0001209191-23-048254:0
97,003 shares@ US$1.273.2% of flowCommon StockSEC:0001209191-23-048254:1
100,000 shares@ US$7.705219.8% of flowCommon StockSEC:0001209191-23-048254:2
26,107 shares@ US$1.270.8% of flowCommon StockSEC:0001209191-23-044845:0
18,715 shares@ US$1.270.6% of flowCommon StockSEC:0001209191-23-044534:0
8,858 shares@ US$1.270.3% of flowCommon StockSEC:0001209191-23-041866:0
26,520 shares@ US$1.270.9% of flowCommon StockSEC:0001209191-23-041716:0
73,059 shares@ US$1.272.4% of flowCommon StockSEC:0001209191-23-034090:0
12,099 sharesCommon StockSEC:0001209191-23-032515:0
43,896 shares@ US$4.585.6% of flowCommon StockSEC:0001209191-23-028507:0
78,740 shares@ US$1.27100.0% of flowCommon StockSEC:0001209191-22-045023:0
68,107 shares0Common StockSEC:0001209191-22-027168:0
27,500 shares0Common StockSEC:0001209191-22-006435:0
23 of 23 declarations
